Viewing Study NCT04704661


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2026-04-15 @ 7:34 PM
Study NCT ID: NCT04704661
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2021-01-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module